Several constitutively active mutant forms of the common b subunit of the human IL-3, IL-5 and GM-CSF receptors (hbc), which enable it to signal in the absence of ligand, have recently been described. Two of these, V449E and I374N, are amino acid substitutions in the transmembrane and extracellular regions of hbc, respectively. A third, FID, contains a 37 amino acid duplication in the extracellular domain. We have shown previously that when expressed in primary murine haemopoietic cells, the extracellular mutants confer factor-independence on cells of the neutrophil and monocyte lineages only, whereas V449E does so on all cell types of the myeloid and erythroid compartments. To study the in vivo eects and leukaemic potential of these mutants, we have expressed all three in mice by bone marrow reconstitution using retrovirally infected donor cells. Expression of the extracellular mutants leads to an early onset, chronic myeloproliferative disorder marked by elevations in the neutrophil, monocyte, erythrocyte and platelet lineages. In contrast, expression of V449E leads to an acute leukaemia-like syndrome of anaemia, thrombocytopaenia and blast cell expansion. These data support the possibility that activating mutations in hbc are involved in haemopoietic disorders in man.
Introduction
The development of the haemopoietic system is achieved by the stringent control of polypeptide growth factors (cytokines), which can act at the level of cell survival, proliferation, dierentiation and functional activation (Metcalf and Nicola, 1995) . One such cytokine, interleukin (IL)-5, exerts its eects on the eosinophil lineage speci®cally. Another, granulocyte-macrophage colony-stimulating factor (GM-CSF), has its actions restricted primarily to the neutrophil and monocyte lineages whilst a third, IL-3 can in¯uence development of all ®ve myeloid lineages as well as the early maturation of erythroid cells.
These three cytokines exert their many functions by binding to speci®c receptors expressed on the surface of responding cells. Their receptors are comprised of two membrane-spanning subunits; speci®c a subunits which bind each growth factor with low anity, but are unable to signal, and a common b subunit (hbc), which cannot detectably bind any of these factors alone, but which complexes with the speci®c a subunits to form a high anity, functional signalling complex (Miyajima et al., 1993) . Both the a and b subunits are members of the cytokine receptor superfamily. Although signalling through the IL-3, IL-5 and GM-CSF receptors requires the cytoplasmic domains of both the a chains and hbc (Sakamaki et al., 1992; Polotskaya et al., 1993; Takaki et al., 1994; Barry et al., 1997) , hbc is thought to be responsible for the majority of signalling through these receptors.
Members of the cytokine receptor superfamily do not possess intrinsic kinase activity. Rather, cytokineinduced substrate phosphorylation is brought about by activation of members of the Janus (JAK) kinase family, which associate with the membrane-proximal intracellular regions of the cytokine receptors and become active upon ligand binding and subsequent receptor dimerization (reviewed in Ihle (1995) ). In the case of the IL-3, IL-5 and GM-CSF receptors, the kinase responsible is JAK2, which is essential for signalling through all three receptors (Parganas et al., 1998) . JAK2 activation leads to the phosphorylation of several substrates, including the transcription factor STAT5 and the intracellular region of hbc.
In addition to its role in normal haemopoiesis, GM-CSF has been implicated in the pathogenesis of a number of leukaemias. Blast cells from acute myeloid leukaemia frequently produce and respond to this factor, reducing or abrogating their requirement for exogenous growth factors in an autocrine manner (Young and Grin, 1986; Young et al., 1987; Kaufman et al., 1988) . Autocrine GM-CSF production has also been found in juvenile chronic myelogenous leukaemia (JCML) and acute lymphoblastic leukaemia (ALL) (Gualtieri et al., 1989; Freedman et al., 1993) . Since the biological eects of GM-CSF are mediated through its receptor, it is possible that constitutively active forms of the GM-CSF receptor (GMR) could contribute to leukaemogenesis through a non-autocrine mechanism.
Indeed, several constitutively active mutants of hbc have recently been discovered that deliver proliferative signals in the absence of growth factors (reviewed by Gonda and D'Andrea, 1997) . One of these, FID, has a 37 amino acid duplication in the extracellular membrane-proximal cytokine receptor domain (CRD), encompassing the conserved WSXWS motif (D'Andrea et al., 1994). Another I374N, has an isoleucine residue in the same CRD replaced by asparagine, whilst a third, V449E, has a transmembrane valine residue replaced by glutamic acid (Jenkins et al., 1995) . These mutants were all identi®ed by their ability to confer factor-independence and tumorigenicity on the otherwise GM-CSF-dependent, non-tumorigenic murine myeloid cell line, FDC-P1. However, when expressed in the murine (m)IL-3-dependent pro-B cell line BAF-B03, only the transmembrane mutant could confer factor-independence on this cell line. This result suggests that transmembrane and extracellular mutants act via dierent mechanisms and that the extracellular mutants require cell-type speci®c molecules for function. In support of this, when expressed in primary murine haemopoietic cells, the extracellular hbc mutants could confer factor-independence on the neutrophil and monocyte lineages only, whereas the transmembrane mutant, V449E, could induce factorindependent development of all the cell types of the myeloid and erythroid compartments (McCormack and Gonda, 1997) . Moreover, the V449E mutant, but not I374N, is constitutively phosphorylated on tyrosine (Jenkins et al., 1998) .
Given the apparent dierences in the signalling properties of transmembrane and extracellular hbc mutants in both primary and transformed murine haemopoietic cells, we wished to study the biological eects of these mutants in vivo. Here we describe the functional analysis of all three hbc mutants in mice using the technique of bone marrow reconstitution. We show that whilst extracellular hbc mutants cause a chronic multilineage myeloproliferative disorder marked by elevations in the neutrophil, monocyte, erythrocyte and platelet lineages, expression of the transmembrane mutant, V449E, causes an acute leukaemia-like syndrome marked by anaemia, thrombocytopaenia and blast cell expansion.
Results

Generation of bone marrow reconstituted by mice containing constitutively active mutant hbc proteins
To express wild-type and mutant hbc proteins in the haemopoietic system of mice, bone marrow cells from 5-Fluorouracil (5-FU) treated mice were infected with the RufNeo retroviral vector containing wild-type hbc, or each of the three constitutively active hbc mutants, (FID, V449E and I374N) and injected into lethally irradiated recipient mice. As a control, mice were injected with cells infected with the RufNeo retroviral vector. Methyl-cellulose plating of infected bone marrow cells showed that the eciency of infection (indicated by G418 resistance) of donor haemopoietic progenitors ranged between 13 and 56% for each of the retroviral constructs used (data not shown).
The donor (BL/6) and recipient (B6.SJL) mice used were of congenic strains expressing antigenically distinct forms of the leukocyte common antigen, Ly5 (Ly5 a and Ly5 b respectively). Flow cytometric analysis of peripheral blood leukocytes of reconstituted mice at 4 weeks post-reconstitution showed that on average 84% of peripheral lymphocytes were of donor origin (data not shown). For simplicity, bone marrow reconstituted mice will be referred to by the cDNA contained in the retrovirus infecting the reconstituting cells, for example`V449E mice' for mice reconstituted with RufNeo-V449E-infected bone marrow cells. Mice reconstituted with wild-type hbc will be designated using single quotation marks, i.e. as``hbc' mice' because, although integrated proviral DNA and expression of RNA was detected, we failed to detect hbc protein on the surface of cells from these animals (see below). Mice reconstituted with RufNeo-infected bone marrow cells will be referred to as`RufNeo mice'.
Haemopoietic disorders induced by hbc expression in mice
None of seven RufNeo mice and nine`hbc' mice developed haemopoietic disorders and/or illness within an 8 month monitoring period. However, ®ve of nine FID mice, ®ve of 17 V449E mice and six of six I374N mice became ill during this period, all of which exhibited haemopoietic disorders (Figure 1 ). Mice exhibiting haemopoietic disorders to the point of becoming moribund will be referred to as`diseased' mice.
Three of ®ve diseased FID mice displayed elevated peripheral blood leukocyte levels ( Figure 2a) . Analysis of nucleated blood cell preparations of diseased FID and I374N mice revealed a decrease in the proportion of lymphocytes, with corresponding increases in the proportion of neutrophils, monocytes and erythroid precursors ( Figure 3 , Table 1 ). These abnormalities were observed for several months prior to the mice becoming moribund (data not shown). A decrease in lymphocytes was also observed in the bone marrow and spleen of these mice, which in the latter organ also corresponded with increases in erythroid precursors and neutrophils (Table 1) . Splenic in®ltration resulted in the enlargement of this organ in all diseased FID mice and two of four diseased I374N mice, with disruption of normal splenic architecture (Figures 2d  and 4) . In®ltrates of neutrophils and erythroid precursors were also present in the livers and lungs of these mice (Figure 4 ). The identities of the lineages aected in the FID and I374N mice were veri®ed by analysis of cell surface antigen expression. A high proportion of splenocytes from these animals were positive for the erythroid marker Ter-119 in comparison with controls. In addition, the proportion of Mac-1 and Gr-1 positive cells was increased while the proportions of cells expressing lymphoid markers CD4, CD8 and B220 were decreased relative to the`hbc' mice (data not shown). 
Numbers are mean+standard deviation of the percentages of at least 200 cells scored.
a Nucleated cell preparations prepared from peripheral blood were used. *P<0.05, **P<0.01, ***P<0.001 compared to hbc (Students' t-test) Figure 4 Histology of haematoxylin and eosin-stained sections of organs derived from bone marrow reconstituted mice. Splenic architecture consisting of clearly de®ned red (R) and white (W) pulp seen in the control (`hbc') mouse is disrupted in the diseased mice which display expanded red pulp, absence of lymphoid germinal centres and megakaryocytes in the spleens of FID and I374N mice (indicated by arrows). Occlusions consisting of erythroid cells and neutrophils are visible in the livers of FID and I374N mice, whilst those consisting of blast cells and neutrophils are present in the liver of a V449E mouse. The spongiform alveoli present in the lung of a control (`hbc') mouse are obstructed by myeloid and erythroid in®ltrates in FID and I374N mice, and an in®ltration of blast cells and neutrophils in the V449E mouse. Bronchioles (b) and blood vessels (v) are marked. Extravascular erythrocytes indicative of pulmonary haemorrhage are visible in the FID mouse lung. Photographs are at 1206 (spleen), 2306 (liver) and 606 (lung) magni®cation and I374N mice also displayed peripheral blood thrombocytosis (Figure 2d ). The spleens of such mice contained clearly discernible megakaryocytes, suggesting that this site may be an origin of this thrombocytosis (Figure 4 ). Hence mice bearing the extracellular hbc mutants, FID and I374N, suer from a chronic, multilineage myeloproliferative disorder characterized by increases in the neutrophil, monocyte, erythrocyte and platelet lineages.
In comparison to the diseased FID and I374N mice, diseased mice bearing the transmembrane hbc mutant, V449E, displayed an altogether distinct phenotype. Unlike the early onset and chronic nature of haemopoietic disorders in FID and I274N mice ( Figure 5 ), disease in V449E mice occurred after a long and variable latency (mean 20 weeks) and was acute in onset (data not shown). Peripheral leukocyte levels were increased in four of ®ve diseased mice; however in these mice blast cells were present in addition to an increased proportion of neutrophils ( Figure 3 , Table 1 ). There was also a large increase in blast cells in the bone marrow of these mice (Table 1) . In®ltrates consisting of blast cells and neutrophils were present in the lungs, livers and spleens of diseased V449E mice, the latter of which were enlarged ( Figure 4, Table 1, Figure 2e ). Surface antigen analysis of a 96% pure population of blasts from the spleen of a diseased V449E mouse showed that these cells exhibited a c-kit low , Thy-1.2 lo , Sca-1+, lin-phenotype (data not shown), which is reminiscent of the most immature subfraction of the haemopoietic system containing the stem cells (Okada et al., 1992; Uchida and Weissman, 1992; Doi et al., 1997) . In contrast to the FID and I374N mice, there was no peripheral blood erythrocytosis or thrombocytosis in the diseased V449E mice; rather, the majority were anaemic and thrombocytopaenic at the time of illness (Figure 2b,d and Figure 5 ). The haematological pro®le of these mice is reminiscent of leukaemias such as acute myeloid leukaemia.
Colony formation by haemopoietic cells derived from bone marrow reconstituted mice
To understand the cellular basis of the eects of constitutively active hbc mutants on murine haemopoiesis in vivo, haemopoietic progenitor assays were carried out using bone marrow and spleen cells derived from diseased bone-marrow reconstituted mice bearing these mutants.
Myeloid and early erythroid progenitors Colony numbers were decreased in the bone marrow of diseased mice bearing the extracellular hbc mutants, FID and I374N (Table 2 ). In contrast, there was an approximately ®vefold increase in progenitors in the spleens of these animals. Hence there is a shift of haemopoietic progenitors from the bone marrow to the spleen in FID and I374N mice. This phenomenon is frequently observed in mice experiencing growth factor-induced myeloproliferative disorders (Chang et al., 1989a,b; Johnson et al., 1989; Nishijima et al., 1997) . The bone marrow and spleen colonies derived from hbc' mice were not G418-resistant, implying that few retrovirus-infected progenitors persist in these mice (Table 2 ). In contrast, a large proportion (39 ± 90%) of progenitors in both marrow and spleen of FID (Table  2 ) and I374N mice were G418-resistant, implying that they contain integrated RufNeo proviruses. Moreover, factor-independent colonies were present in the bone marrow and spleen of diseased FID mice. All of these were granulocyte, macrophage or mixed granulocytemacrophage colonies, which is consistent with the restriction of the eects of FID on murine haemopoiesis in vitro to these lineages (McCormack and . Surprisingly however, factor-independent colonies were not obtained from I374N mice (Table 2) .
In contrast to the FID and I374N mice, V449E mice contained a signi®cantly increased number of progenitors in the bone marrow and spleen (Table 2 ). Further analysis revealed that these represented many dierent types, including granulocyte, macrophage erythroid, mast and mixed colonies (data not shown). However, the proportion of retrovirally-infected (G418-resistant) progenitors in the V449E mice was low (2 and 14% in bone marrow and spleen respectively), and no factorindependent colonies were obtained from either site from these mice ( Table 2 ), implying that there is an increase of non-infected progenitors in these mice.
Late erythroid progenitors There was a vast increase in the number of erythroid colony forming units (CFU-E) in the spleens of mice bearing either extracellular mutant, a large proportion of which were G418-resistant (indicating that they contain the RufNeo provirus) (Figure 6 ). Moreover, the number of CFU-E was slightly decreased in the bone marrow of diseased FID mice and increased in that of I374N mice (data not shown). Importantly, high levels of growth factorindependent CFU-E were present in the spleen ( Figure  6 ) and bone marrow (data not shown) of mice bearing the extracellular hbc mutants.
In contrast, CFU-E were absent in the bone marrow of diseased V449E mice (data not shown) and were not increased in the spleen of these mice, which is consistent with their anaemic phenotype ( Figure 6 , see above). Moreover, factor-independent CFU-E were not present in the bone marrow or spleen of V449E mice. Hence mice bearing extracellular but not transmembrane hbc mutants exhibited factor-independent erythropoiesis.
hbc expression in reconstituted mice
To verify that reconstituted mice expressed hbc, we performed RT ± PCR analysis on haemopoietic cells from these animals. Figure 7a (left panel) shows that RNA from nucleated blood cells of diseased V449E, FID and I374N mice, but not untreated control mice, gave rise to PCR products of the expected sizes 7225 bp for V449E and I374N (i.e. the same as WT hbc), and 336 bp for FID (due to the 111 bp insertion in this mutant ). Note that no products were detected when reverse transcriptase was omitted, showing that the observed bands represented RNA and not contaminating genomic DNA. Figure 7a (right panel) also shows that expression of WT hbc RNA could be detected in spleen cells from`hbc' mice. To examine expression of hbc protein, bone marrow cell preparations from control and reconstituted mice Figure 6 Mice bearing extracellular but not transmembrane hbc mutations display factor-independent erythropoiesis. Numbers of CFU-E in the spleen of control and bone marrow reconstituted mice. Cells were plated in methyl-cellulose alone (open bars) or in the presence of growth factors (50 ng/ml mSCF plus 2 U/ml hEpo (®lled bars) or growth factors plus 1 mg/ml G418 (dashed bars). Numbers of CFU-E were determined after 2 days incubation. Numbers are the means of triplicate determinations. Error bars show the standard deviation of the mean Bone marrow cell preparations from control (B6.SJL) or bone marrow reconstituted mice were stained with a cocktail of biotinylated anti-hbc monoclonal antibodies (3D7, QP1, 1C1, represented by solid lines) or a biotinylated irrelevant isotype control antibody (dashed lines) followed by streptavidin-phycoerythrin and analysed by¯ow cytometry as described in Materials and methods were analysed by¯ow cytometry using a cocktail of monoclonal antibodies speci®c for hbc. As shown in Figure 7b , these antibodies did not react with bone marrow cells derived from a control (B6.SJL) mouse, however hbc expression was detected on cells derived from diseased mice bearing all three hbc mutants. Immunohistochemical analyses demonstrated that the hbc protein was expressed in a variety of cell types: both erythroid and myeloid precursors in FID and I374N mice and blast cells and neutrophils in V449E mice (data not shown). Despite the fact that the hbc cDNA was integrated into the genome of three out of three`hbc' mice tested using PCR (data not shown), and that expression of RNA could be detected by RT ± PCR (see above), expression of hbc protein was not detectable on bone marrow cells derived from`hbc' mice (data not shown). It may be that constitutively active hbc mutants lead to upregulation of hbc expression or selective expansion of expressing cells.
Discussion
This study shows the results of expression of three activated mutants of the human GM-CSF receptor b subunit in mice. In summary, irradiated mice receiving bone marrow cells infected with RufNeo-FID or RufNeo-I374N developed chronic, lethal myeloproliferative syndromes characterized by neutrophilia, erythrocytosis, thrombocytosis and often monocytosis in the blood, accompanied by splenomegaly and myeloid and erythroid in®ltration of the spleen, liver and lung. In contrast, irradiated mice receiving bone marrow cells infected with RufNeo-V449E developed acute, lethal leukaemia-like disorders characterized by blast cells in the blood, anaemia, splenomegaly and in®ltration of blast cells and neutrophils into the spleen, liver and lung. This is the ®rst example of dierent mutants of a single growth factor receptor causing distinct haemopoietic disorders in vivo. These results highlight a potential contribution of duplication or point mutation of hbc to human myeloproliferative disease and leukaemia.
Implications for involvement of FID and I374N in disease
The clinical features of FID and I374N mice are broadly similar, which is supportive of the previous hypotheses that these mutants signal via similar mechanisms (Jenkins et al., 1995; McCormack and Gonda, 1997) . Many clinical features of the FID and I374N mice were also observed in mice transgenic for the a and b subunits of the hGM-CSF receptor (hGMR) when treated with human GM-CSF (Nishijima et al., 1997) . For example, these mice also developed neutrophilia and monocytosis in the blood, as well as enlarged spleens containing erythroid precursors. However, these mice also displayed lymphocytosis in the blood and spleen, which was not observed here. Explanation for this dierence comes from molecular studies of the signalling of the extracellular mutants, which have shown that I374N associates with the murine GM-CSF receptor (mGMR) a subunit and that this mutant as well as FID require co-expression of mGMRa for function in murine factor-dependent cell lines (Jenkins et al. (1999) ; R D'Andrea, personal communication). By analogy, it is likely that the function of these mutants in vivo is restricted to cells that, unlike lymphocytes, express mGMRa.
Indeed, factor-independent granulocyte-macrophage colonies were present in the bone marrow and spleen of diseased FID mice, providing an explanation for the neutrophilia and monocytosis of these mice (Tables 1  and 2 , and data not shown). However, factor independent colonies were not obtained from I374N mice (data not shown), and the neutrophilia seen in the I374N mice was less severe than that of FID mice (Figure 2a, Table 1) . Hence it appears that the actions of I374N on the granulocyte-macrophage lineages in vivo are weaker than those of FID.
In addition to neutrophilia and monocytosis, FID and I374N mice develop early onset, chronic erythrocytosis, apparently due to factor-independent CFU-E development in the bone marrow and spleen (Figure 6 ). However, it is unlikely that erythroid cells express mGMRa, as murine GM-CSF does not elicit murine erythroid development in vitro or in vivo (Metcalf et al., 1986a,b; . Moreover, de Jong et al. (1997) were unable to detect GMRa expression on erythroid precursors. Thus the factor-independent CFU-E present in mice bearing the extracellular hbc mutants are probably not due to the formation of active heterodimeric complexes between the mutants and mGMRa. Experiments are currently underway to determine the molecular mechanism of factor-independent erythroid colony formation in these mice.
Thrombocytosis was also observed in some FID and I374N mice (Figure 2d ). Increased thrombopoiesis was not observed in mice expressing GM-CSF in transgenesis or bone marrow reconstitution models, nor in transgenic mice expressing the hGMR treated with human GM-CSF; hence the thrombocytosis observed in FID and I374N mice in this study is unlikely to be an eect of these mutants signalling in conjunction with mGMRa (Lang et al., 1987; Johnson et al., 1989; Nishijima et al., 1997) . Hence in addition to their previously documented ability to confer factor independence on the granulocyte-macrophage lineages, this study has shown an ability of these mutants to function in the erythrocyte and megakaryocyte lineages.
The neutrophilia and erythrocytosis observed in the FID and I374N mice in this study were also found in transgenic mice expressing the FID mutant under control of a`housekeeping' gene promoter (D'Andrea et al., 1998). However, these features were more severe in the FID mice in this study, and thrombocytosis was also found in these mice, hence the bone marrow reconstitution technique employed here appears to elicit a more severe phenotype than that found in FID transgenics. This may re¯ect the higher expression levels derived from the retroviral promoter. Since the expression of hbc mutants in this study is restricted to the haemopoietic compartment, this study implies that the similar phenotype of mice bearing FID is due to a direct action of this mutant in haemopoietic cells.
Implications for involvement of V449E in disease
Mice reconstituted with V449E suer from acute leukaemia characterized by accumulation of blast cells in the blood, spleen, liver and lung. In support of our classi®cation, this disorder was transplantable into sublethally irradiated secondary recipients, whereas the chronic disorders of mice containing the extracellular mutants were not (data not shown). Disease occurred in only a proportion reconstituted V449E mice (®ve of 17), implying that further mutations are required for oncogenicity in addition to V449E signalling. This is reminiscent of our previous ®nding that factor-independent cell lines generated by expression of V449E in foetal liver cells are tumorigenic in only a proportion of mice, implying that subsequent mutations are required for full oncogenicity (McCormack and Gonda, 1997) .
Virally infected progenitors were present in the bone marrow and spleen of diseased V449E mice as measured by G418 resistance, however these remained growth factor-dependent and were morphologically normal, hence are distinct from the leukaemic blast cells in these mice (Table 2 and data not shown). Moreover, transformed cell lines were not obtained from the bone marrow of these mice by culture in the absence of growth factors or in the presence of growth factors including IL-3, GM-CSF, Epo or SCF (data not shown). Thus it appears that a signal(s) additional to those generated by V449E ± and not generated by factors present in our culture systems ± is required for proliferation of these blast cells. A further understanding of the contribution of V449E to the leukaemic phenotype of V449E mice may require a more detailed analysis of these mice in the early, asymptomatic phase.
Transmembrane and extracellular hbc mutants generate distinct haemopoietic disorders in vivo
The more restricted phenotype of V449E mice is the opposite of what might be predicted from the in vitro studies using these mutants, in which FID and I374N stimulate development of the granulocyte-macrophage lineages only, whereas V449E can signal to all myeloid and erythroid cell types (McCormack and Gonda, 1997) . Moreover, the disorder seen in V449E mice is unlike that seen when murine IL-3 or GM-CSF (which activate murine bc) are expressed in mice via a similar protocol (Chang et al., 1989a; Johnson et al., 1989) . These mice develop lethal non-neoplastic myeloproliferative syndromes without leukaemia. There are at least two possible explanations for this discrepancy. Firstly, the receptors for murine IL-3 and GM-CSF may not be expressed on certain immature subpopulations of murine haemopoietic cells which are susceptible to leukaemic transformation by factorindependent signalling. Alternatively, the dierent biological eects of V449E and IL-3/GM-CSF in vivo may be explained by the unique signalling eects of V449E identi®ed in vitro. When expressed in foetal liver cells, V449E leads to abnormally extended proliferation of immature haemopoietic cells when compared to FID/I374N or the wild-type murine IL-3/GM-CSF receptors, and exhibits a partial defect in inducing macrophage development (McCormack and Gonda, 1997) . This defect in dierentiative signalling may explain the lack of chronic myeloid or erythroid hyperplasia in V449E mice, and would be likely to increase the leukaemogenic potential of V449E. Future studies aimed at further clarifying the signalling dierences between these two classes of hbc mutants may provide important information regarding the types of signals leading to chronic myeloproliferative disorders and leukaemia. 
Materials and methods
Cytokines
Cell lines and cDNAs
C2 ecotropic retrovirus packaging cells (Mann et al., 1983) were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% foetal calf serum (FCS). Transfected pools were maintained in the above medium plus 200 mg/ml G418 (geneticin, GIBCO, Grand Island, NY, USA).
The hbc cDNA used here was that described by Barry et al. (1994) . The FID (D'Andrea et al., 1994), V449E and I374N (Jenkins et al., 1995) hbc mutants have been described previously.
Bone marrow reconstitution
Eight week-old male C57BL/6J mice (donor mice) were injected intraperitoneally with 150 mg/kg 5-¯uorouracil (5-FU, Faulding, David Bull Laboratories, Victoria, Australia). Four days post-injection, the mice were sacri®ced and bone marrow harvested. The bone marrow cells derived from one mouse femur were co-cultivated with 10 6 C2 retroviral packaging cells expressing the RufNeo retrovirus or RufNeo viruses containing wild-type or mutant hbc cDNAs in Iscove's modi®ed Dulbecco's medium (IMDM) containing 15% FCS, 500 U/ml mIL-3, 10 ng/ml hIL-6 and 100 ng/ml mSCF. After a 3 day incubation period, 8-week-old female B6.SJL mice (recipient mice) were lethally irradiated with two doses of ®ve Grays each, 4 h apart, from a Caesium 137 source in an IBL Blood Product Irradiator. The irradiated recipients were injected intravenously with the infected 5-FU treated cells derived from one donor mouse femur. Mice were maintained in sterile conditions, monitored weekly and their peripheral blood analysed monthly. At the ®rst sign of illness mice were sacri®ced and their haemopoietic tissues analysed.
Blood analysis
Mice were bled from the retro-orbital plexus under anaesthesia. The blood was diluted one in ®ve in PBS and the levels of leukocytes, erythrocytes, platelets, haemoglobin and packed cell volume were analysed using a Coulter blood analyser (Coulter Electronics, Hileah, FL, USA) with results multiplied to allow for dilution. To obtain nucleated blood cells, erythrocytes were lysed using a solution of one part 20 mM Tris pH 7.65 added to nine parts 0.83% (w/v) ammonium chloride, for 10 min on ice.
Flow cytometry
Biotinylated anti-hbc (3D7) MoAb was obtained from PharMingen (San Diego, CA, USA) and biotinylated antihbc MoAbs QP1 and 1C1 were generously provided by Dr Angel Lopez (Hanson Centre for Cancer Research, Adelaide, South Australia). Cells were incubated with the above antibodies followed by staining with phycoerythrin-conjugated streptavidin (Caltag Laboratories, San Francisco, CA, USA) and analysed by¯ow cytometry using an Epics II Pro®le analyser (Coulter Electronics).
Colony assays
To assay CFU-E, 5610 4 bone marrow cells or 5610 5 spleen cells were plated in 1 ml methyl-cellulose medium. Where indicated 2 U/ml hEpo, 50 ng/ml mSCF and 1 mg/ml G418 were added. After 2 days incubation, 1 ml of a solution of 1 mg/ml 3'-3'-diaminobenzidine (ICN Biomedicals, Seven Hills, NSW, Australia) and 0.015% (v/v) hydrogen peroxide in PBS was carefully layered on top of the methylcellulose. After 5 min at room temperature, colonies of 58 haemoglobinized cells were scored as CFU-E with the aid of an inverted microscope.
To assay other colony types, 10 4 5-FU treated bone marrow cells, 2610 4 foetal liver cells, 5610 4 bone marrow cells and 5610 5 spleen cells were cultured in 1 ml methylcellulose medium. Where indicated 500 U/ml mIL-3, 500 U/ ml mGM-CSF, 50 ng/ml mSCF, 2 U/ml hEpo and 1 mg/ml G418 were added. Colonies containing greater than 50 cells were scored at the seventh day of culture with the aid of a dissecting microscope using indirect lighting. To assess colony types, individual colonies were removed at days 7 ± 11 of culture using a micropipette, spread on glass slides using compressed air until dry as described by Metcalf (1984) , stained with Wright-Giemsa and the colony types determined microscopically.
Histological analysis of organs
Mice were dissected and the whole or part organs ®xed in 10% neutral buered formalin for at least 16 h. These specimens were paran embedded, sectioned at 5 mm and stained with haematoxylin and eosin.
Reverse-transcription ± polymerase chain reaction (RT ± PCR) analysis of hbc expression Total RNA was prepared from splenocytes or nucleated blood cells using the Trizol reagent (Life Technologies, Rockville, Maryland, USA), and RT ± PCR was performed using a GeneAmp RNA PCR kit (Perkin-Elmer, Foster City, California, USA) essentially following the manufacturers' protocols with the following variations and parameters. Reverse transcription was performed using random hexamer primers. Forward and reverse PCR primers corresponded to nucleotides 1172 ± 1191 and 1369 ± 1388, respectively, of the hbc cDNA sequence (Barry et al., 1994) . PCR cycling parameters were: 948C for 4 min; 40 cycles of (948C for 1 min, 608C for 30 s, 728C for 30 s); 728C for 5 min. Products were analysed by electrophoresis on a 1.8% agarose gel.
